ERIC POSTEL, M.D.
Medical Practice at Erwin Rd, Durham, NC

License number
North Carolina 96-01057
Category
Medical Practice
Type
Ophthalmology
Address
Address
2100 Erwin Rd, Durham, NC 27710
Phone
(919) 620-4467

Personal information

See more information about ERIC POSTEL at radaris.com
Name
Address
Phone
Eric Postel, age 58
3623 Carlisle Dr, Durham, NC 27707
Eric Attila Postel, age 60
327 Northcreek Dr, Durham, NC 27707
Eric Attila Postel, age 60
1012 Demerius St, Durham, NC 27701
(919) 682-6897
Eric Attila Postel, age 60
3320 Executive Dr, Raleigh, NC 27609
(919) 876-2427
Eric Attila Postel, age 58
3623 Carlisle Dr, Durham, NC 27707
(919) 403-0718

Organization information

See more information about ERIC POSTEL at bizstanding.com

Eric Postel MD

PO Box 3802, Durham, NC 27702

Industry:
Ophthalmology, Surgeons
Phone:
(919) 684-3891 (Phone)
Eric Attila Postel

Professional information

Eric Postel Photo 1

Dr. Eric Postel, Durham NC - MD (Doctor of Medicine)

Specialties:
Ophthalmology
Address:
Duke Eye Center
2351 Erwin Rd, Durham 27705
(919) 681-3937 (Phone)
Certifications:
Ophthalmology, 1996
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
Duke Eye Center
2351 Erwin Rd, Durham 27705
Duke Health Raleigh Hospital
3400 Wake Forest Rd, Raleigh 27609
Duke University Hospital
2301 Erwin Rd, Durham 27710
Durham Regional Hospital
3643 North Roxboro Rd, Durham 27704
Education:
Medical School
Thomas Jefferson University
Graduated: 1991
The Miriam Hosp
Duke U Eye Ctr
Med Coll Wisc Eye Inst


Eric A Postel Photo 2

Eric A Postel, Durham NC

Specialties:
Ophthalmologist
Address:
2100 Erwin Rd, Durham, NC 27705
Education:
Thomas Jefferson University, Jefferson Medical College - Doctor of Medicine
Duke University Hospital - Residency - Ophthalmology
Board certifications:
American Board of Ophthalmology Certification in Ophthalmology


Eric Postel Photo 3

Eric Postel, Durham NC

Specialties:
Ophthalmology, Surgery
Work:
Durham Va Medical Center
508 Fulton St, Durham, NC 27705 Private Diagnostic Clinic PLLC
3480 Wake Forest Rd, Raleigh, NC 27609 Private Diagnostic Clinic
2351 Erwin Rd, Durham, NC 27710
Education:
Thomas Jefferson University (1991)


Eric Postel Photo 4

Miniaturized Surgical Instruments Especially Useful For The Opthalmologic Surgical Procedures And Methods Of Making The Same

US Patent:
6491670, Dec 10, 2002
Filed:
Apr 4, 2000
Appl. No.:
09/542985
Inventors:
Cynthia A. Toth - Durham NC
Ronald F. Overaker - Durham NC
Brian C. Dodge - Durham NC
Eric A. Postel - Durham NC
Brooks W. McCuen - Durham NC
Assignee:
Duke University - Durham NC
International Classification:
A61M 500
US Classification:
604264
Abstract:
Surgical instruments, especially for opthalmological surgical procedures, have a smooth, bulbous arcuate tip that surrounds the distal end of a lumen. The tip may be translucent and flexible. Most preferably, the tip is formed of a compliant, yet self-supporting, material, such as medical grade transparent silicone elastomer. The bulbous arcuate tip may take various geometric forms, for example, generally spherical, ellipsoid or the like. The bulbous arcuate tip may be symmetrical about the elongate axis of the instrument or may be asymmetrical (i. e. , angularly disposed) relative to such longitudinal axis. The surgical instruments of this invention are most preferably made by first adhering a length of compliant tubing (e. g. , silicone) onto a distal end of a rigid tube (e. g. , a section of a stainless steel needle).


Eric Postel Photo 5

Genetic Variants Increase The Risk Of Age-Related Macular Degeneration

US Patent:
8088587, Jan 3, 2012
Filed:
Mar 6, 2006
Appl. No.:
11/885336
Inventors:
Jonathan L. Haines - Nashville TN, US
Eric Postel - Durham NC, US
Anita Agarwal - Nashville TN, US
Michael A. Hauser - Durham NC, US
Silke Schmidt - Durham NC, US
William K. Scott - Durham NC, US
Assignee:
Vanderbilt University - Nashville TN
Duke University - Durham NC
International Classification:
G01N 31/00, G01N 33/53
US Classification:
435 71, 435 4, 4352879, 436501, 436518, 436525, 436529, 436535, 436809, 530300, 530350, 422 50
Abstract:
Age-related macular degeneration (AMD) is a leading cause of visual impairment and blindness in the elderly whose etiology remains largely unknown. Previous studies identified chromosome 1q32 as harboring a susceptibility locus for AMD, but it was not identified. We identified a strongly associated haplotype in two independent data sets. DNA sequencing of the complement factor II gene (CFII) within this haplotype revealed a coding variant, Y402II, that significantly increases the risk for AMD with odds ratios between 2. 45 and 5. 57. This identifies Complement factor II as involved in pathogenesis of AMD. This single variant alone is so common that it likely explains 43 percent of AMD in older adults. In addition, we have replicated and refined previous reports implicating a coding change in LOC387715 as the second major AMD susceptibility allele. The effect of rs10490924 appears to be completely independent of the Y402H variant in the CFH gene.


Eric Postel Photo 6

Peripheral Reticular Pigmentary Change And Age-Related Macular Degeneration

US Patent:
2010014, Jun 10, 2010
Filed:
Nov 12, 2009
Appl. No.:
12/617256
Inventors:
Eric A. Postel - Durham NC, US
R. Keith Shuler - Durham NC, US
Jennifer Vaughn Caldwell - Durham NC, US
Michael Hauser - Durham NC, US
Silke Schmidt - Durham NC, US
Assignee:
DUKE UNIVERSITY - Durham NC
International Classification:
A61B 3/14, A61F 9/00, A61B 3/10
US Classification:
600558, 351206
Abstract:
Examination of 956 age-related macular degeneration cases showed that the complement factor H variant (Y402H, C allele at rs1061170) increases risk for the development of peripheral reticular pigmentary change. AMD phenotypes of 796 carriers of the CFH Y402H variant were compared to the AMD phenotypes of 160 non-carriers. Of 34 phenotypic features analyzed, only peripheral reticular pigmentary change (PRPC) was associated with this CFH variant (P-value 0.0006). The proportion of AMD cases with PRPC correlated with the number of CFH risk C alleles in a dose-response fashion. The association of CFH Y402H polymorphism with PRPC suggests that AMD changes are not limited to the macula. Current AMD grading methods assess only the macula; peripheral retinal changes should also be included in grading methods. PRPC may be used as a surrogate of a high-risk genotype and may be used for diagnostic, therapeutic, and research purposes.


Eric Postel Photo 7

Phenotype-Genotype Relationship In Age-Related Macular Degeneration

US Patent:
2009026, Oct 22, 2009
Filed:
Jan 2, 2009
Appl. No.:
12/348167
Inventors:
Eric A. Postel - Durham NC, US
Jennifer Caldwell - Durham NC, US
Silke Schmidt - Durham NC, US
Michael Hauser - Durham NC, US
Assignee:
Duke University - Durham NC
International Classification:
C12Q 1/68, G01N 33/535, C12Q 1/02
US Classification:
435 6, 435 792, 435 29
Abstract:
Age-Related Macular Degeneration (AMD) cases possessing the LOC387715 (rs10490924) variant have a higher risk of neovascular AMD. Individuals with AMD who are homozygous for both variants might be at greater risk for earlier onset of neovascular AMD. Determining the presence of this variant indicates which path the disease may take and which nutritional, supplement, or medicaments are appropriate.


Eric Postel Photo 8

Phenotype-Genotype Relationship In Age-Related Macular Degeneration

US Patent:
2011018, Jul 28, 2011
Filed:
Feb 28, 2011
Appl. No.:
13/036780
Inventors:
Eric A. Postel - Durham NC, US
Jennifer Caldwell - Durham NC, US
Silke Schmidt - Durham NC, US
Michael Hauser - Durham NC, US
Assignee:
DUKE UNIVERSITY - Durham NC
International Classification:
C12Q 1/68, G01N 33/53
US Classification:
435 612, 435 61, 435 71, 435 792
Abstract:
Age-Related Macular Degeneration (AMD) cases possessing the LOC387715 (rs 10490924) variant have a higher risk of neovascular AMD. Individuals with AMD who are homozygous for both variants might be at greater risk for earlier onset of neovascular AMD. Determining the presence of this variant indicates which path the disease may take and which nutritional, supplement, or medicaments are appropriate.